Farallon Capital Management’s Bausch Health BHC Stock Holding History

Farallon Capital Management’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-650,000	Closed	-$93M	–	96
2014 Q4	$93M	Hold	650,000	–	–	1.27%	31
2014 Q3	$85.3M	Hold	650,000	–	–	1.37%	29
2014 Q2	$82M	Buy	+650,000	New	+$82.9M	1.18%	29

Other funds holding BHC

PSCM

Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Farallon Capital Management's BHC Position: Q2 2016 in Review

Farallon Capital Management sold out of Bausch Health (BHC) in Q2 2016, closing a stake of 269,700 shares — an estimated $7.09M sold.

Farallon Capital Management first reported a position in BHC in Q2 2014 and held it in 7 quarters. The position peaked at $57.1M in Q3 2014. 347 funds tracked by Wall St. Rank hold BHC as of Q2 2016.

Farallon Capital Management reported no remaining Bausch Health position as of Q2 2016 after selling out during the quarter.
Farallon Capital Management sold 269,700 Bausch Health shares in Q2 2016, an estimated $7.09M.
Farallon Capital Management first reported a position in Bausch Health in Q2 2014 and held it in 7 quarters.
Farallon Capital Management's Bausch Health position peaked at $57.1M in Q3 2014.
347 funds tracked by Wall St. Rank held Bausch Health as of Q2 2016.

Based on Farallon Capital Management's 13F filing for Q2 2016, filed 15 Aug 2016.